As per the research report, the size of the North America Contrast Injector Market is valued at USD 181.46 million in 2023 and is expected to be growing at a CAGR of 8.2%, to touch USD 269.11 million by 2028 during the forecast period 2023 to 2028.
The approvals from many governments and contrast agents are increasing, advancements in new technologies, and growing investments and funding are helping the North American contrast injector market grow.
Medical imaging is crucial in determining the disease and the image's accuracy in the health sector. The medical imaging devices are helping the global contrast injector market in improvement. One of the main drivers of the market is the growing awareness about the injectors, and their uses are boosting the market in a significant way. It is also increasing the demand for the market. The applications for this market are improving with the help of the new technologies being created with the help of the increasing new investments. Many software and IT companies are helping in creating new solutions. These are boosting the market significantly and increasing the market growth.
Recently CT systems are using a new type of injectors. They use two back-to-back injectors during the imaging process. It increases the accuracy of the imaging process. It also helps gather the details of the patient and his radiation reading during the process. Many key players in North America are investing in this market, and the government is also helping the market propel with giving approvals. Due to this investment, new methods are being introduced in the use of imaging systems. This helps in the more unique capabilities of the imaging systems. The integration of IT and contrast media dose management are also a vital part of the growth of the contrast injector market.
Many companies are partnering up in creating new and better systems. Contrast dose tracking is also introduced by partnering. A new approach is presented in collecting and analyzing the data in the imaging procedure.
These are the major drivers that boost the market and are expected to boost and improve the market in the present and forecast period.
The lack of professionals is hampering the demand for the market to handle the equipment. In addition, the side effects associated with contrast injectors are limiting the market growth. Some people are getting side effects due to overuse of contrast injectors such as skin redness, vomiting, or dizziness. Further, the manufacturing and maintenance cost are high.
This research report on the North America Contrast Injector Market has been segmented and sub-segmented into the following categories:
Geographically, North America is expected to have the largest market share. The market growth is significantly fueled by the increasing prevalence of chronic diseases, advanced healthcare infrastructure, and favorable reimbursement policies. On the other hand, the changing lifestyles and the growing preference for contrast injectors are uplifting the market growth.
The U.S Contrast Injector Market accounted for the largest share of the contrast injectors market, and it is predicted to record a predominant share during the forecast period. Technological advancements, high healthcare spending, and growing awareness about contrast injectors. The number of people affected by heart diseases increases in North America as per Heart Disease & Stroke Statistical Fact Sheet 2022.
These are mainly being affected in infants. Therefore, treatments for infants are growing In the United States. The increasing investments from the key players are growing and helping the research and development assist them in creating new technological advancements. However, the product the approvals from governments are also boosting the market.
KEY MARKET PLAYERS
Companies playing a dominant role in the North America Contrast Injector Market profiled in this report are Bracco Imaging S.p.A. (Italy), Bayer HealthCare (Germany), Guerbet Group (France), Medtron AG (Germany), ulrich GmbH & Co. KG (Germany), GE Healthcare (U.S.), AngioDynamics (U.S.), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd. (China), VIVID IMAGING (China), and Apollo RT Co., Ltd. (China).,
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com